Nucleic Acids Research, 2000, Vol. 28, No. 1 346-348
© 2000 Oxford University Press
Human Immunodeficiency Virus Reverse Transcriptase and Protease Sequence Database
Department of Medicine, 1Department of Engineering and 2Department of Computer Science Stanford University, Stanford, CA 94305, USA
The HIV RT and Protease Sequence Database is an online relational database that catalogs evolutionary and drug-related human immunodeficiency virus (HIV) reverse transcriptase (RT) and protease sequence variation (http://hivdb.stanford.edu ). The database contains a compilation of nearly all published HIV RT and protease sequences including International Collaboration database submissions (e.g., GenBank) and sequences published in journal articles. Sequences are linked to data about the source of the sequence sample and the antiretroviral drug treatment history of the individual from whom the isolate was obtained. The database is curated and sequences are annotated with data from >230 literature references. Users can retrieve additional data and view alignments of sequence sets meeting specific criteria (e.g., treatment history, subtype, presence of a particular mutation). A gene-specific sequence analysis program, new user-defined queries and nearly 2000 additional sequences were added in 1999.
* To whom correspondence should be addressed at: Division of Infectious Diseases, Stanford University Medical Center, Stanford, CA 94305, USA. Tel: +1 650 725 2946; Fax: +1 650 725 2395; Email: rshafer@cmgm.stanford.edu
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
J. Snoeck, R. Kantor, R. W. Shafer, K. Van Laethem, K. Deforche, A. P. Carvalho, B. Wynhoven, M. A. Soares, P. Cane, J. Clarke, et al. Discordances between Interpretation Algorithms for Genotypic Resistance to Protease and Reverse Transcriptase Inhibitors of Human Immunodeficiency Virus Are Subtype Dependent Antimicrob. Agents Chemother., February 1, 2006; 50(2): 694 - 701. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. C. Logsdon, J. F. Vickrey, P. Martin, G. Proteasa, J. I. Koepke, S. R. Terlecky, Z. Wawrzak, M. A. Winters, T. C. Merigan, and L. C. Kovari Crystal Structures of a Multidrug-Resistant Human Immunodeficiency Virus Type 1 Protease Reveal an Expanded Active-Site Cavity J. Virol., March 15, 2004; 78(6): 3123 - 3132. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Zazzi, L. Romano, G. Venturi, R. W. Shafer, C. Reid, F. Dal Bello, C. Parolin, G. Palu, and P. E. Valensin Comparative evaluation of three computerized algorithms for prediction of antiretroviral susceptibility from HIV type 1 genotype J. Antimicrob. Chemother., February 1, 2004; 53(2): 356 - 360. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-C. Lin, Z. Beck, G. M. Morris, A. J. Olson, and J. H. Elder Structural Basis for Distinctions between Substrate and Inhibitor Specificities for Feline Immunodeficiency Virus and Human Immunodeficiency Virus Proteases J. Virol., June 15, 2003; 77(12): 6589 - 6600. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Watkins, W. Resch, D. Irlbeck, and R. Swanstrom Selection of High-Level Resistance to Human Immunodeficiency Virus Type 1 Protease Inhibitors Antimicrob. Agents Chemother., February 1, 2003; 47(2): 759 - 769. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Aslanzadeh HIV Resistance Testing: an Update Ann. Clin. Lab. Sci., October 1, 2002; 32(4): 406 - 413. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Resch, R. Ziermann, N. Parkin, A. Gamarnik, and R. Swanstrom Nelfinavir-Resistant, Amprenavir-Hypersusceptible Strains of Human Immunodeficiency Virus Type 1 Carrying an N88S Mutation in Protease Have Reduced Infectivity, Reduced Replication Capacity, and Reduced Fitness and Process the Gag Polyprotein Precursor Aberrantly J. Virol., July 29, 2002; 76(17): 8659 - 8666. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. A. Beck, M. Mahalanabis, G. Pepper, A. Wright, S. Hamilton, E. Langston, and L. M. Frenkel Rapid and Sensitive Oligonucleotide Ligation Assay for Detection of Mutations in Human Immunodeficiency Virus Type 1 Associated with High-Level Resistance to Protease Inhibitors J. Clin. Microbiol., April 1, 2002; 40(4): 1413 - 1419. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. W. Shafer, K. Hertogs, A. R. Zolopa, A. Warford, S. Bloor, B. J. Betts, T. C. Merigan, R. Harrigan, and B. A. Larder High Degree of Interlaboratory Reproducibility of Human Immunodeficiency Virus Type 1 Protease and Reverse Transcriptase Sequencing of Plasma Samples from Heavily Treated Patients J. Clin. Microbiol., April 1, 2001; 39(4): 1522 - 1529. [Abstract] [Full Text] |
||||
![]() |
M. M. Alba, D. Lee, F. M. G. Pearl, A. J. Shepherd, N. Martin, C. A. Orengo, and P. Kellam VIDA: a virus database system for the organization of animal virus genome open reading frames Nucleic Acids Res., January 1, 2001; 29(1): 133 - 136. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Kantor, R. Machekano, M. J. Gonzales, K. Dupnik, J. M. Schapiro, and R. W. Shafer Human Immunodeficiency Virus Reverse Transcriptase and Protease Sequence Database: an expanded data model integrating natural language text and sequence analysis programs Nucleic Acids Res., January 1, 2001; 29(1): 296 - 299. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Resch, N. Parkin, E. L. Stuelke, T. Watkins, and R. Swanstrom A multiple-site-specific heteroduplex tracking assay as a tool for the study of viral population dynamics PNAS, December 14, 2000; (2000) 11511298. [Abstract] [Full Text] |
||||
![]() |
W. Resch, N. Parkin, E. L. Stuelke, T. Watkins, and R. Swanstrom A multiple-site-specific heteroduplex tracking assay as a tool for the study of viral population dynamics PNAS, January 2, 2001; 98(1): 176 - 181. [Abstract] [Full Text] [PDF] |
||||






